​​Minimally invasive,
robotic therapeutic delivery.

• Percutaneous, sub-xiphoid access.
• Real-time 3D display and intuitive control interface enables integrated procedure planning.
• Robotically controlled, disposable HeartLander device “walks” along the epicardium like an inchworm to reach the target injection site, using atraumatic suction feet.
• Delivery platform moves with the heart surface and carries injectable therapy and scaffolds.